Exicure Inc Stock News
$7.38
2.64%
yesterday
Nasdaq,
Aug 12, 10:04 pm CET
Exicure Inc Stock News
Negative
The Motley Fool
●
4 days ago
Exicure Posts Wider Loss in Fiscal Q2
Neutral
Business Wire
●
4 days ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Reports Second Quarter 2025 Financial Results.
Neutral
Business Wire
●
8 days ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements.
Neutral
Business Wire
●
11 days ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients.
Neutral
Business Wire
●
about 2 months ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Q1 2025 earnings release.
Neutral
Business Wire
●
3 months ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q.
Neutral
Business Wire
●
3 months ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant.
Neutral
Business Wire
●
4 months ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
